China Health's market value is the price at which a share of China Health trades on a public exchange. It measures the collective expectations of China Health Industries investors about its performance. China Health is trading at 1.0E-4 as of the 5th of January 2026, a No Change since the beginning of the trading day. The stock's lowest day price was 1.0E-4. With this module, you can estimate the performance of a buy and hold strategy of China Health Industries and determine expected loss or profit from investing in China Health over a given investment horizon. Check out China Health Correlation, China Health Volatility and China Health Alpha and Beta module to complement your research on China Health.
Please note, there is a significant difference between China Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if China Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, China Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
China Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to China Health's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of China Health.
0.00
01/16/2024
No Change 0.00
0.0
In 1 year 11 months and 22 days
01/05/2026
0.00
If you would invest 0.00 in China Health on January 16, 2024 and sell it all today you would earn a total of 0.00 from holding China Health Industries or generate 0.0% return on investment in China Health over 720 days. China Health is related to or competes with Luff Enterprises, Mydecine Innovations, BioQuest Corp, Medicure, and Eco Growth. China Health Industries Holdings, Inc., through its subsidiaries, manufactures and sells health products More
China Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure China Health's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess China Health Industries upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for China Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as China Health's standard deviation. In reality, there are many statistical measures that can use China Health historical prices to predict the future China Health's volatility.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as China Health. Your research has to be compared to or analyzed against China Health's peers to derive any actionable benefits. When done correctly, China Health's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in China Health Industries.
China Health Industries Backtested Returns
China Health Industries secures Sharpe Ratio (or Efficiency) of -0.12, which signifies that the company had a -0.12 % return per unit of risk over the last 3 months. China Health Industries exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm China Health's Risk Adjusted Performance of (0.08), mean deviation of 2.98, and Standard Deviation of 12.3 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -1.13, which signifies a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning China Health are expected to decrease slowly. On the other hand, during market turmoil, China Health is expected to outperform it slightly. At this point, China Health Industries has a negative expected return of -1.56%. Please make sure to confirm China Health's information ratio, as well as the relationship between the skewness and day median price , to decide if China Health Industries performance from the past will be repeated at some point in the near future.
Auto-correlation
0.30
Below average predictability
China Health Industries has below average predictability. Overlapping area represents the amount of predictability between China Health time series from 16th of January 2024 to 10th of January 2025 and 10th of January 2025 to 5th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of China Health Industries price movement. The serial correlation of 0.3 indicates that nearly 30.0% of current China Health price fluctuation can be explain by its past prices.
Correlation Coefficient
0.3
Spearman Rank Test
-0.14
Residual Average
0.0
Price Variance
0.01
China Health Industries lagged returns against current returns
Autocorrelation, which is China Health pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting China Health's pink sheet expected returns. We can calculate the autocorrelation of China Health returns to help us make a trade decision. For example, suppose you find that China Health has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
China Health regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If China Health pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if China Health pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in China Health pink sheet over time.
Current vs Lagged Prices
Timeline
China Health Lagged Returns
When evaluating China Health's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of China Health pink sheet have on its future price. China Health autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, China Health autocorrelation shows the relationship between China Health pink sheet current value and its past values and can show if there is a momentum factor associated with investing in China Health Industries.
Regressed Prices
Timeline
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Other Information on Investing in China Pink Sheet
China Health financial ratios help investors to determine whether China Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China Health security.